Word

Status

Registered

Status Code

700

Status Date

Tuesday, November 24, 2020

Serial Number

88453131

Registration Number

6206673

Registration Date

Tuesday, November 24, 2020

Mark Type

2000

Filing Date

Thursday, May 30, 2019

Published for Opposition

Tuesday, March 3, 2020

Trademark Owner History

AZURITY PHARMACEUTICALS, INC. - Original Registrant
CutisPharma, Inc. - Owner At Publication

Classifications

5 pharmaceutical preparations sold as a kit for use by pharmacists and physicians in creating compounded hormone replacement medicines, topical anti-inflammatory and ultrasound gels, pain and gastrointestinal disorders treatment medicines, and anti-inflammatory, antimicrobial, and antifungal treatment medicines; medicines for the treatment of cardiovascular diseases and disorders, colitis, muscle spasm, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders; antibiotics; pharmaceutical products for the treatment of pain, thyroid disorders, gastrointestinal disorders, gastroesophageal disorders, inflammation, infections, fungal diseases and disorders, cardiovascular diseases and disorders, colitis, muscle spasm, attention deficit hyperactivity disorders, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders having vancomycin, enalapril, lisinopril, and methotrexate as the active pharmaceutical ingredient; antacids; muscle relaxants; hormone replacement medicines; topical anti-inflammatory and ultrasound gels; pharmaceutical preparation for the treatment of pain, thyroid disorders, gastrointestinal disorders, gastroesophageal disorders, inflammation, infections, fungal diseases and disorders, cardiovascular diseases and disorders, colitis, muscle spasm, attention deficit hyperactivity disorders, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders; pharmaceuticals for use in the treatment of cancer and autoimmune diseases and disorders, and for the treatment and prevention of renal, oncological, inflammatory, gastrointestinal, gastroesophageal, and cardio-vascular diseases and disorders

The color(s) dark orange, orange, yellow, green, turquoise, dark turquoise, light blue, blue, navy, and purple is/are claimed as a feature of the mark.
The mark consists of a series of generally hexagonal shaded polygons forming a swirl with a shaded circle at the top of the swirl, with the shapes being colored dark orange, orange, yellow, green, turquoise, dark turquoise, light blue, blue, navy, and purple.

Trademark Events

Nov 24, 2020

Registered-Principal Register

Oct 22, 2020

Notice Of Acceptance Of Statement Of Use E-Mailed

Oct 21, 2020

Allowed Principal Register - Sou Accepted

Oct 21, 2020

Statement Of Use Processing Complete

Oct 6, 2020

Use Amendment Filed

Oct 20, 2020

Case Assigned To Intent To Use Paralegal

Oct 6, 2020

Teas Statement Of Use Received

Apr 29, 2020

Automatic Update Of Assignment Of Ownership

Apr 28, 2020

Noa E-Mailed - Sou Required From Applicant

Mar 3, 2020

Official Gazette Publication Confirmation E-Mailed

Mar 3, 2020

Published For Opposition

Feb 12, 2020

Notification Of Notice Of Publication E-Mailed

Jan 30, 2020

Approved For Pub - Principal Register

Jan 29, 2020

Teas/Email Correspondence Entered

Jan 29, 2020

Correspondence Received In Law Office

Jan 29, 2020

Teas Response To Office Action Received

Aug 9, 2019

Notification Of Non-Final Action E-Mailed

Aug 9, 2019

Non-Final Action E-Mailed

Aug 9, 2019

Non-Final Action Written

Aug 8, 2019

Assigned To Examiner

Jun 15, 2019

Notice Of Design Search Code E-Mailed

Jun 14, 2019

New Application Office Supplied Data Entered In Tram

Jun 3, 2019

New Application Entered In Tram